Baillie Gifford & CO Penumbra Inc Transaction History
Baillie Gifford & CO
- $127 Billion
- Q4 2024
A detailed history of Baillie Gifford & CO transactions in Penumbra Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 730,233 shares of PEN stock, worth $221 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
730,233
Previous 591,846
23.38%
Holding current value
$221 Million
Previous $115 Million
50.91%
% of portfolio
0.14%
Previous 0.09%
Shares
30 transactions
Others Institutions Holding PEN
# of Institutions
409Shares Held
29.2MCall Options Held
254KPut Options Held
43.3K-
Black Rock Inc. New York, NY4.26MShares$1.29 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$1.11 Billion0.02% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.5MShares$453 Million2.36% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.27MShares$384 Million0.03% of portfolio
-
State Street Corp Boston, MA1.2MShares$365 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $11.5B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...